Tetraphase Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference

WATERTOWN, Mass., July 1, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that company management will present at the Cantor Fitzgerald Inaugural Healthcare Conference on Wednesday, July 8th at 2:30 p.m. Eastern Time at Le Parker Meridien Hotel in New York City.

A live audio webcast of the Cantor presentation will be available on the company's website at http://ir.tphase.com/events.cfm.  An archived presentation will be available for 90 days.

About Tetraphase Pharmaceuticals, Inc.

Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening MDR bacterial infections, including those caused by many of the MDR Gram-negative bacteria highlighted as urgent public health threats by the CDC. Tetraphase has created more than 3,000 novel tetracycline analogs using its proprietary technology platform. Tetraphase's pipeline includes eravacycline, a broad-spectrum intravenous and oral antibiotic that is being evaluated in phase 3 clinical trials, and two preclinical antibiotic candidates, TP-271 and TP-6076. Please visit www.tphase.com for more company information.

CONTACT: Investor Contacts:
         Tetraphase Pharmaceuticals
         Teri Dahlman
         617-600-7040
         [email protected]

         Argot Partners
         Susan Kim
         212-600-1902
         [email protected]

         Media Contact:
         Sam Brown Inc.
         Mariesa Kemble
         608-850-4745
         [email protected]

You May Also Be Interested In

• Market Turns Red, But Apeing Surges Ahead: Could This 2,400% ROI Crypto Become the Best Crypto to Buy Now? 
• KIVO Takes the Global Stage at Crypto Expo Dubai 2026
• Order Execution Under Pressure: What Every Trader Needs to Know